BANK VONTOBEL/PUT/NOVO NORDISK ADR B/110/0.1/17.01.25 | Market Closed - Boerse Frankfurt Warrants 11:21:37 01/07/2024 pm IST | ||
| 0.194 EUR | -10.19% |
|
| Current month | -10.19% | ||
| 1 month | -42.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 01/24/01 | 0.194 | -10.19% |
| 28/24/28 | 0.216 | -2.26% |
| 27/24/27 | 0.221 | -3.91% |
| 26/24/26 | 0.23 | +10.05% |
| 25/24/25 | 0.209 | -10.30% |
Real-time Boerse Frankfurt Warrants
Last update July 01, 2024 at 11:21 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Vontobel
|
| WKN | VM9CS4 |
| ISIN | DE000VM9CS45 |
| Date issued | 30/01/2024 |
| Strike | 110 $ |
| Maturity | 17/01/2025 (200 Days) |
| Parity | 10 : 1 |
| Emission price | 1.09 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.1 € |
|---|---|
| Lowest since issue | 0.194 € |
| Delta | -0.1x |
| Omega | 7.052 |
| Premium | 25.91x |
| Gearing | 69.91x |
| Moneyness | 0.7552 |
| Difference Strike | -35.42 $ |
| Difference Strike % | -32.20% |
| Spread | 0.01 € |
| Spread % | 5.03% |
| Theoretical value | 0.1940 |
| Implied Volatility | 35.75 % |
| Total Loss Probability | 84.61 % |
| Intrinsic value | 0.000000 |
| Present value | 0.1940 |
| Break even | 107.92 € |
| Theta | -0.01x |
| Vega | 0.02x |
| Rho | -0.01x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,005
DKK
Average target price
950.4
DKK
Spread / Average Target
-5.39%
- Stock Market
- Warrants
- Warrant
